Multimodality imaging using proton magnetic resonance spectroscopic imaging and 18F-fluorodeoxyglucose-positron emission tomography in local prostate cancer

Table 1 Patient characteristics

		n (%)
Clinical stage1	T1c	10 (45.5)
	T2a	4 (18.2)
	T2b	4 (18.2)
	T2c	1 (4.5)
	T3	1 (4.5)
	T3a	2 (9.1)
Biopsy Gleason score	0 + 0	1 (4.5)
	3 + 3	3 (13.6)
	3 + 4	5 (22.7)
	4 + 3	5 (22.7)
	4 + 4	4 (18.2)
	4 + 5	4 (18.2)
Pathology stage	pT2a	3 (13.6)
	pT2b	5 (22.7)
	pT3a	7 (31.8)
	pT3b	6 (27.3)
	pT4	1 (4.5)
Pathology Gleason score	3 + 3	1 (4.5)
	3 + 4	8 (36.4)
	4 + 3	4 (18.2)
	4 + 4	4 (18.2)
	4 + 5	3 (13.6)
	5 + 4	1 (4.5)
	Not Graded2	1 (4.5)
Prior radiation treatment	EBRT	11 (50)
	Untreated	11 (50)

¹Clinical stage was determined prior to primary or salvage surgery;

²One index tumor was not graded due to treatment effect. EBRT: External beam radiation therapy.